These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 9988795

  • 1. Telomerase activity in complete hydatidiform mole.
    Bae SN, Kim SJ.
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):328-33. PubMed ID: 9988795
    [Abstract] [Full Text] [Related]

  • 2. Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles.
    Amezcua CA, Bahador A, Naidu YM, Felix JC.
    Am J Obstet Gynecol; 2001 Jun; 184(7):1441-6. PubMed ID: 11408866
    [Abstract] [Full Text] [Related]

  • 3. Telomerase activity in gestational trophoblastic disease.
    Cheung AN, Zhang DK, Liu Y, Ngan HY, Shen DH, Tsao SW.
    J Clin Pathol; 1999 Aug; 52(8):588-92. PubMed ID: 10645228
    [Abstract] [Full Text] [Related]

  • 4. Telomerase activity in complete hydatidiform mole.
    Sukcharoen N, Mutirangura A, Limpongsanurak S.
    J Reprod Med; 1999 May; 44(5):465-70. PubMed ID: 10360262
    [Abstract] [Full Text] [Related]

  • 5. Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.
    Hajri T, Massoud M, Vergne M, Descargues P, Allias F, You B, Lotz JP, Haesebaert J, Bolze PA, Golfier F, Massardier J.
    Am J Obstet Gynecol; 2024 Mar; 230(3):362.e1-362.e8. PubMed ID: 37722570
    [Abstract] [Full Text] [Related]

  • 6. Analysis of 309 cases after hydatidiform mole: different follow-up program according to biologic behavior.
    Bolis G, Belloni C, Bonazzi C, Mangili G, Presti M, Zanaboni F, Mangioni C.
    Tumori; 1988 Feb 29; 74(1):93-6. PubMed ID: 2451334
    [Abstract] [Full Text] [Related]

  • 7. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
    Lin LH, Maestá I, St Laurent JD, Hasselblatt KT, Horowitz NS, Goldstein DP, Quade BJ, Sun SY, Braga A, Fisher RA, Berkowitz RS, Elias KM.
    Am J Obstet Gynecol; 2021 Apr 29; 224(4):372.e1-372.e30. PubMed ID: 33031755
    [Abstract] [Full Text] [Related]

  • 8. Telomerase activity and the subunit of telomerase in hydatidiform mole and their relationship with the development of postmolar tumor.
    Wang F, Huang H, Kang X, Chen B, Li Y.
    Eur J Gynaecol Oncol; 2006 Apr 29; 27(5):473-6. PubMed ID: 17139981
    [Abstract] [Full Text] [Related]

  • 9. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
    Stone M, Bagshawe KD.
    Br J Obstet Gynaecol; 1979 Oct 29; 86(10):782-92. PubMed ID: 228696
    [Abstract] [Full Text] [Related]

  • 10. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I, Hansen ES, Sunde L.
    Gynecol Oncol; 2007 Feb 29; 104(2):411-5. PubMed ID: 17011616
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE, Sweep FC, Schijf CP, Massuger LF, Thomas CM.
    Eur J Endocrinol; 2005 Oct 29; 153(4):565-75. PubMed ID: 16189178
    [Abstract] [Full Text] [Related]

  • 12. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
    Harsono AB, Hidayat YM, Winarno GNA, Nisa AS, Alkaff FF.
    Am J Case Rep; 2021 Jun 15; 22():e931156. PubMed ID: 34127641
    [Abstract] [Full Text] [Related]

  • 13. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
    Yang X, Zhang Z, Jia C, Li J, Yin L, Jiang S.
    Gynecol Oncol; 2002 Jun 15; 85(3):438-44. PubMed ID: 12051871
    [Abstract] [Full Text] [Related]

  • 14. Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor.
    Lage JM, Berkowitz RS, Rice LW, Goldstein DP, Bernstein MR, Weinberg DS.
    Obstet Gynecol; 1991 Jan 15; 77(1):111-5. PubMed ID: 1845777
    [Abstract] [Full Text] [Related]

  • 15. Down-regulation of poly(rC)-binding protein 1 correlates with the malignant transformation of hydatidiform moles.
    Shi Z, Zhang T, Long W, Wang X, Zhang X, Ling X, Ding H.
    Int J Gynecol Cancer; 2012 Sep 15; 22(7):1125-9. PubMed ID: 22801034
    [Abstract] [Full Text] [Related]

  • 16. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI.
    Gynecol Oncol; 2000 Jul 15; 78(1):39-42. PubMed ID: 10873407
    [Abstract] [Full Text] [Related]

  • 17. Expression of telomerase subunits and localization of telomerase activation in hydatidiform mole.
    Nishi H, Ohyashiki K, Fujito A, Yahata N, Ohyashiki JH, Isaka K, Takayama M.
    Placenta; 1999 May 15; 20(4):317-23. PubMed ID: 10329353
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and significance of implantation site trophoblastic atypia in hydatidiform moles and spontaneous abortions.
    Montes M, Roberts D, Berkowitz RS, Genest DR.
    Am J Clin Pathol; 1996 Apr 15; 105(4):411-6. PubMed ID: 8604683
    [Abstract] [Full Text] [Related]

  • 19. Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies.
    Chen RJ, Chu CT, Huang SC, Chow SN, Hsieh CY.
    Hum Reprod; 2002 Feb 15; 17(2):463-8. PubMed ID: 11821296
    [Abstract] [Full Text] [Related]

  • 20. Hydatidiform moles.
    Heath JM, Bu TH, Brereton WF.
    Am Fam Physician; 1985 May 15; 31(5):123-31. PubMed ID: 2581433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.